News
Astra Zeneca Partners with Helix for Drug Discovery
5+ hour, 40+ min ago (344+ words) All Sci Astra Zeneca has signed a multi-year agreement with San Mateo-based Helix to access its Geno Sphere clinico-genomic cohort platform for drug discovery and development, adding a major US commercial data source to its existing population genomics infrastructure. The…...
Xiaflex Wins FDA Approval for Plantar Fibromatosis
2+ hour, 31+ min ago (475+ words) Xiaflex wins first-ever FDA approval pathway for plantar fibromatosis with Phase III success All Sci Keenova Therapeutics has reported that collagenase clostridium histolyticum (Xiaflex) met its primary endpoint in a pivotal Phase III trial for plantar fibromatosis " a condition also…...
Boehringer Ingelheim Acquires Cancer Vaccine Platform
5+ hour, 35+ min ago (485+ words) Boehringer Ingelheim acquires viral vector platform for cancer vaccines from Prime Vector All Sci Boehringer Ingelheim has entered a license agreement with Germany-based Prime Vector Technologies Gmb H (PVT) to acquire exclusive rights to its Orf virus (ORFV) viral vector…...
UChicago Engineers Bacteria for Pancreatic Cancer
5+ hour, 39+ min ago (331+ words) All Sci The University of Chicago has received a USD 1. 75 million National Cancer Institute R01 award to develop genetically engineered Bifidobacterium as a systemic delivery vehicle for immunotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC), one of the cancers least responsive to…...
Beckman Coulter's CE-Marked p-Tau217 Blood Test
1+ day, 6+ hour ago (557+ words) enables scalable Alzheimer's screening in routine labs All Sci Beckman Coulter has become the latest diagnostics company to secure European regulatory clearance for a blood-based Alzheimer's biomarker assay, underscoring intensifying competition to supply scalable patient-selection tools as disease-modifying therapies expand....
VCU Advances Dual EGFR/HER2 Lung Cancer Strategy
1+ day, 6+ hour ago (300+ words) All Sci Virginia Commonwealth University (VCU) has received a USD 1. 74 million National Cancer Institute R01 award to advance preclinical evaluation of PEPDG278 D, a recombinant human protein designed to degrade both EGFR and HER2 in non-small cell lung cancer " including tumors resistant to…...
Agenus Achieves 33% Three-Year Survival in Colorectal Cancer
2+ day, 1+ hour ago (716+ words) All Sci Agenus Inc. (Nasdaq: AGEN) reported three-year overall survival data from its Phase Ib C-800-01 trial at ESMO GI 2026 in Munich, showing that 33% of patients with refractory microsatellite-stable (MSS) metastatic colorectal cancer without active liver metastases were alive at 36 months…...
CDH17 Antibody-Drug Conjugate Shows Promise in. ..
2+ day, 4+ hour ago (720+ words) All Sci Interim Phase I data from China-based Multitude Therapeutics reported a 20% overall response rate and a 91% disease control rate for AMT-676, a CDH17-directed antibody-drug conjugate, in heavily pretreated metastatic colorectal cancer patients " results that, while early, suggest the target…...
Brii Bio's Hepatitis B Strategy Validated
2+ day, 5+ hour ago (653+ words) All Sci Brii Biosciences Limited, dual-head-quartered in Beijing, China, and North Carolina, reported end-of-treatment data from two Phase IIb studies that clarify the optimal combination strategy for BRII-179 in chronic HBV. However, a legal dispute with Vir Biotechnology (Nasdaq: VIR)…...
MSK Builds Diverse Stem Cell Knockout Catalog
6+ day, 55+ min ago (288+ words) All Sci Memorial Sloan-Kettering Cancer Center has received a USD 1. 78 million NIH UM1 renewal to continue building a large-scale catalog of human gene knockout phenotypes across genetically diverse stem cell lines " work that could sharpen understanding of how gene loss drives…...